|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 38/17 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| A61K 38/1709 | (2013.01) | ||
| C07K 14/4703 | (2013.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| C07K 14/4705 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07K 14/705 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 14/7155 | (2013.01) | ||
| C07K 14/715 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 39/001122 | (2018.08) | ||
| A61K 39/00115 | (2018.08) | ||
| A61K 39/001119 | (2018.08) | ||
| A61K 39/001192 | (2018.08) | ||
| A61K 39/001153 | (2018.08) |
| (11) | Patento numeris | 3511013 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18211075.9 |
| Europos patento paraiškos padavimo data | 2011-08-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-09-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 37658210 P | 2010-08-24 | US |
| (72) |
Okada, Hideho , US
|
| (73) |
University of Pittsburgh - Of the Commonwealth
System of Higher Education ,
1st Floor Gardner Steel Conference Center
130 Thackeray Avenue, Pittsburgh, PA 15260,
US
|
| (54) | INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES |
| INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES |